Health Sciences Acquisitions Corporation 2 HSAQ

Full chart Compare
Set alert

Price alert · HSAQ

All alert types
13.31 0.00 (+0.00%)

Jan 26, 2023, 3:59 PM EST

10.44 Day range 13.50
9.41 52-week range 13.80

Financial health

Altman Z-Score

-3.04 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -12.0×
FY 2020: -1490×FY 2021: -563×FY 2022: -66.5×FY 2024: -8.0×FY 2025: -12.0×
FY 2020 5y median -66.5× FY 2025
P/S 15262×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 185780×FY 2025: 15262×
FY 2020 5y median 0.0× FY 2025
P/B 9539×
FY 2020: 1.7×FY 2021: -51.8×FY 2022: -23.6×FY 2024: 14870×FY 2025: 9539×
FY 2020 5y median 1.7× FY 2025
P/FCF -10333×
FY 2020: -1005×FY 2021: -750×FY 2022: -104×FY 2024: -9638×FY 2025: -10333×
FY 2020 5y median -1005× FY 2025
EV/EBITDA -9863×
FY 2020: -1485×FY 2021: -535×FY 2022: -59.9×FY 2024: 1591130×FY 2025: -9863×
FY 2020 5y median -535× FY 2025
EV/Sales 15261×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 185773×FY 2025: 15261×
FY 2020 5y median 0.0× FY 2025
FCF Yield -0.0%
FY 2020: -0.1%FY 2021: -0.1%FY 2022: -1.0%FY 2024: -0.0%FY 2025: -0.0%
FY 2020 5y median -0.1% FY 2025

Profitability

Gross Margin 99.4%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 92.3%FY 2025: 99.4%
FY 2020 5y median 0.0% FY 2025
Operating Margin -154.7%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: -2437.5%FY 2025: -154.7%
FY 2020 5y median 0.0% FY 2025
Net Margin -158.2%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: -2313.3%FY 2025: -158.2%
FY 2020 5y median 0.0% FY 2025
ROE -98.9%
FY 2020: -0.1%FY 2021: 9.2%FY 2022: 34.4%FY 2024: -185.2%FY 2025: -98.9%
FY 2020 5y median -0.1% FY 2025
ROIC -52.4%
FY 2020: -0.1%FY 2021: -0.2%FY 2022: -4.1%FY 2024: -106.3%FY 2025: -52.4%
FY 2020 5y median -4.1% FY 2025
ROA -46.1%
FY 2020: -0.1%FY 2021: -0.2%FY 2022: -3.5%FY 2024: -80.1%FY 2025: -46.1%
FY 2020 5y median -3.5% FY 2025

Growth (YoY)

Revenue 1169.2%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 1169.2%
FY 2020 FY 2025
Operating Income 19.4%
FY 2020: 0.0%FY 2021: -127.5%FY 2022: -680.3%FY 2024: 0.0%FY 2025: 19.4%
FY 2020 FY 2025
EPS (diluted) 33.1%
FY 2020: 0.0%FY 2021: -108.1%FY 2022: -738.0%FY 2024: 0.0%FY 2025: 33.1%
FY 2020 FY 2025
Free Cash Flow 2.7%
FY 2020: 0.0%FY 2021: -5.4%FY 2022: -479.9%FY 2024: 0.0%FY 2025: 2.7%
FY 2020 FY 2025

Financial Health

Current Ratio 6.4×
FY 2020: 18.1×FY 2021: 10.9×FY 2022: 0.2×FY 2024: 4.3×FY 2025: 6.4×
FY 2020 5y median 6.4× FY 2025
Quick Ratio 6.4×
FY 2020: 18.1×FY 2021: 10.9×FY 2022: 0.2×FY 2024: 4.3×FY 2025: 6.4×
FY 2020 5y median 6.4× FY 2025
Debt / Equity 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2020: 11.7×FY 2021: 4.6×FY 2022: 0.1×FY 2024: -65.0×FY 2025: 0.6×
FY 2020 5y median 0.6× FY 2025
Interest Coverage 45.1×
FY 2020: 0.0×FY 2021: 24.7×FY 2022: 8.9×FY 2024: 0.0×FY 2025: 45.1×
FY 2020 5y median 8.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31